Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Regenerx Biopharmaceuticals Inc. (RGRX)

Total paid for Promotions this month: $0
E-mails this Month: 7
Estimated Volume Generated: $0
Research Report on RGRX: Click to see
* The information presented is based on information for Mar , 2016
RegenRx Bio (RGRX) RegeneRx Biopharmaceuticals, Inc. (RGRX) is focused on the development of novel therapeutic peptides, including Thymosin beta 4 and its constituent fragments, for tissue and organ protection, repair and regeneration.   The company currently has three drug candidates in clinical development for ophthalmic, cardiac and dermal indications, three active strategic licensing agreements in the U.S., ...read more
Promoter: PPS Alerts Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
RegenRx Bio (RGRX) RegeneRx Biopharmaceuticals, Inc. (RGRX) is focused on the development of novel therapeutic peptides, including Thymosin beta 4 and its constituent fragments, for tissue and organ protection, repair and regeneration.   The company currently has three drug candidates in clinical development for ophthalmic, cardiac and dermal indications, three active strategic licensing agreements in the U.S., ...read more
Promoter: PST Alerts Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
RegenRx Bio (RGRX) RegeneRx Biopharmaceuticals, Inc. (RGRX) is focused on the development of novel therapeutic peptides, including Thymosin beta 4 and its constituent fragments, for tissue and organ protection, repair and regeneration.   The company currently has three drug candidates in clinical development for ophthalmic, cardiac and dermal indications, three active strategic licensing agreements in the U.S., ...read more
Promoter: Buzz Stocks Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 0.00 % Gain at close: Pending
      Tomorow's Pick is: RGRX     MC Members, We've discovered a new BioPharma pick that I believe could stage an absolutely massive rally over the next few weeks. But before we begin… It’s important that all members read this report in its entirety so you understand exactly why this company, stands head-and-shoulders above the competition. This clinical stage ...read more
Promoter: The MarketCaliber Team Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 15.97 % Gain at close: Pending
//   Tomorrows Breakout Alert is: RGRX Secret Stock Members,   I’ve discovered a new BioPharma pick that I believe could stage an absolutely massive rally over the next few weeks.   But before I begin…   It’s important that all members read this report in its entirety so you understand exactly why this company, stands head-and-shoulders above the competition.   This clinical stage BioPharma company ...read more
Promoter: SecretStockPromoter Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 15.97 % Gain at close: Pending
    PICK FOR: Thurs, March 24th, 2016 OTC: RGRX             RegineRX Biopharmaceuticals (RGRX)!             Attention Traders!     We’ve discovered a new BioPharma pick that we believe could stage an absolutely massive rally over the next few weeks.     But before we begin…      It’s important ...read more
Promoter: Penny Pick Finders Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 15.97 % Gain at close: Pending
PSP Free Members I’ve discovered a new BioPharma pick that I believe could stage an absolutely massive rally over the next few weeks. But before I begin… It’s important that all members read this report in its entirety so you understand exactly why this company, stands head-and-shoulders above the competition. This clinical stage BioPharma company is trading at just .65 pps, and just ...read more
Promoter: Penny Stock Prophet Paying Party: No Third Party
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX No compensation UNKNOWN
Max Profit: 15.97 % Gain at close: Pending
SeeThruEquity Issues Update on RegeneRx Biopharmaceuticals, Inc. Highlighting Clinical Trial Progress October 28, 2015 9:15am New York, NY--(Accesswire) - SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced it has issued an update on RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX).   The report ...read more
Promoter: SeeThruEquity Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
RGRX Unknown compensation UNKNOWN
Max Profit: 5.88 % Gain at close: Pending
Video not found or You must install the Flash Plugin for your Browser in order to view this movie